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Synthesis and Evaluation of Protein-Phenylboronic Acid 
Conjugates as Lectin Mimetics
Joshua Whited, Czharena Kay Rama, and Xue-Long Sun*®
Department of Chemistry, Chemical and Biomedical Engineering and Center for Gene Regulation of Health and Disease (GRHD), 
Cleveland State University, Cleveland, Ohio 44115, United States
ABSTRACT: Glycan-binding molecules, such as lectins, are 
very important tools for characterizing, imaging, or targeting 
glycans and are often involved in either physiological or 
pathological processes. However, their availability is far less 
compared to the diversity of native glycans. Therefore, 
development of lectin mimetics with desired specificity and 
affinity is in high demand. Boronic acid reacts with 1,2- and 
1,3-diols of saccharides in aqueous media through reversible 
boronate ester formation and are regarded as synthetic lectin 
mimetics. In this study, bovine serum albumin (BSA)-
phenylboronic acid (PBA) conjugates were synthesized in a
density-controlled manner by targeting both aspartic and 
glutamic acids to afford lectin mimetics with multivalent PBA,
as multivalency is a key factor for glycan recognition in both specificity and affinity. The resultant BSA-PBA conjugates were 
characterized by sodium dodecyl sulfate polyacrylamide gel electrophoresis and matrix-assisted laser desorption/ionization time- 
of-flight mass spectrometry analysis. Their macrophage cell surface glycan-binding capacity was characterized by a competitive 
lectin-binding assay examined by flow cytometry, and 3-(4,5-di-methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay 
showed biocompatibility. These novel lectin mimetics will find a broad range of applications as they can be wittingly modified, 
altering binding specificity and capacity.
■ INTRODUCTION
Carbohydrate recognition is a crucial event in many biological 
processes.1 For example, cell surface glycans, existing as 
glycoproteins, glycolipids, or proteoglycans, are involved in a 
variety of biological processes, including cellular adhesion, cell 
signaling, cell-cell communication, and immune response.2-4 
Cell surface glycans are highly associated with disease 
development, such as inflammation and cancer.5,6 Over­
expression of cell surface glycans is confirmed in cancer cells 
compared to healthy cells used as a control.7 Therefore, 
sensitive profiling of cell surface glycans is highly demanded for 
basic glycomic advancement, clinical diagnostics, and ther­
apeutic applications. In fact, the diversity and complexity of 
glycan structures, together with their crucial role in many 
physiological or pathological processes, require the develop­
ment of new techniques for analysis. Lectins are carbohydrate­
binding proteins having at least one noncatalytic domain that 
binds reversibly to a specific carbohydrate.8 Due to their 
specificity, they have been employed to identify cell surface 
glycans and glycoconjugates. Fluorescently labeled lectins have 
been widely used as intracellular and extracellular labels for 
cellular glycan profiling.9-11 Further, lectin arrays using lectins 
as probes are well established to determine specific glycan 
markers among different cell populations.12 In addition, lectins 
are also used for cellular targeting, showing promise in 
biomedical applications, including targeting of apoptotic and 
autophagic pathways useful in anticancer therapies.13 Although
natural lectins are very important tools for glycoscience 
research and application, they also have major limitations, 
such as difficulty in production, instability toward rigorous use, 
high cost, and lack of availability.14 Another limiting factor is 
low binding affinity and specificity leading to poor sensitivity 
for analytical assays because rarely is any glycan found at high 
abundance in a biological sample.15 In an effort to mitigate 
these limitations, clustered or linked lectins have been explored 
because of the important role of multivalency in glycan- 
protein interactions.16,17
Boronic acids (BAs) react with 1,2- and 1,3-diols of 
saccharides in aqueous media through reversible boronate 
ester formation.18-20 This interaction has been explored for 
potential applications in the analysis of glycans and 
glycoconjugates. So far, BA-containing ligands have been 
employed as artificial carbohydrate receptors,21,22 membrane 
transport agents,22 and cell surface carbohydrate recognition 
ligands.23 It has been reported that phenylboronic acid (PBA) 
can selectively bind to the glycerol side chain of sialic acids 
(SAs) under physiological conditions, and the complex is 
stabilized through coordination of the amide NH or CO 
located at the C-5 position of SAs.24 This anomalous binding 
profile of PBA strongly suggests an innovative molecular
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targeting platform for selective recognition of cell surface SA 
residues of both glycoproteins and glycolipids. To further 
investigate the glycan-binding ability of multivalent lectin 
mimetics, we designed protein-PBA conjugates to elucidate 
cell surface SA capabilities and evaluate their application as 
synthetic lectin mimetics. Specifically, bovine serum albumin 
(BSA)-PBA conjugates were synthesized in a density- 
controlled manner by targeting both aspartic and glutamic 
acids to afford the lectin mimetics with multivalent PBA, as 
multivalence is a key factor for glycan-protein binding in both 
specificity and affinity. The resultant BSA-PBA conjugates 
were characterized by sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) and matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry 
(MALDI-TOF MS) analysis. Further, its cell surface glycan- 
binding capacity was confirmed by competitive lectin-binding 
assay examined by flow cytometry.
Scheme 1. Synthesis of BSA-PBA Conjugates
M BSA 1 2 3 M BSA 1 2 3 M BSA 1 2 3
Figure 1. SDS-PAGE analysis of EDC coupling of BSA to 3-PBA. (A) All protein bands visualized by Coomassie blue staining. (B) BSA-PBA 
bands visualized by ARS staining. (C) Fluorescent images of conjugated BSA-PBA bands stained with ARS (M: protein molecular weight marker; 
BSA: bovine serum albumin; 1: BSA-PBA1; 2: BSA-PBA2; and 3: BSA-PBA3).
Figure 2. Characterization of BSA-PBA conjugates by MALDI-TOF MS. (A) MALDI-TOF MS-spectra of (1) BSA, (2) BSA-PBA1, (3) BSA- 
PBA2, and (4) BSA-PBA3 obtained by reacting BSA with PBA in different ratios in the presence of EDC; (B) MALDI-TOF MS spectra of (1) 
BSA and (2-4) BSA mixed with PBA in different ratios but without EDC.
■ RESULTS AND DISCUSSION
Synthesis and Characterization of BSA-PBA Con­
jugates. Considering PBA's ability to reversibly bind 1,2- and 
1,3-diols in aqueous media along with BSA's well-tolerated and 
widespread application, BSA-PBA conjugates were designed 
as lectin mimetics and were synthesized via N-(3- 
(dimethylamino)propyl)-N-ethylcarbodiimide hydrochloride 
(EDC) coupling. In this instance, amidation of carboxylic 
acids in BSA was followed by conjugation with 3-amino- 
phenylboronic acid in the presence of EDC dissolved in 2-(N- 
morpholino)ethane sulfonic (MES) buffer (Scheme 1). The 
resultant BSA-PBA conjugates were purified on a Hi-Trap 
Sephadex G-25 column by using diH2O as eluent. Different 
densities of BSA-PBA conjugates were synthesized by altering 
the ratio of PBA to BSA.
The resultant BSA-PBA conjugates were characterized by 
SDS-PAGE gel with Coomassie blue and Alizarin Red S (ARS)
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staining assay. First, BSA-PBA conjugates were characterized 
by SDS-PAGE, where they showed an increase in molecular 
weight (Figure 1A). ARS binds to PBA in a 1:1 ratio, and a 
dramatic change in color and UV-vis and fluorescent 
absorption spectra can be monitored. Therefore, the BSA- 
PBA conjugates characterized on SDS-PAGE were stained with 
ARS. As shown in Figure 1B, clear yellowish spots of all three 
BSA-PBA conjugates were observed, but not for unmodified 
BSA. In the same respect, fluorescent signals were obtained for 
all three BSA-PBA conjugates, but not for the BSA on the gel 
under fluorescence scanner (Figure 1C). These data confirmed 
that the BSA-PBA conjugates were successfully synthesized.
Next, MALDI-TOF MS was used to characterize the BSA- 
PBA conjugates using a sinapic acid matrix with a Bruker 
Autoflex III mass spectrometer. The mass spectrum acquired 
for unmodified BSA showed the typical profile of a 
nonglycosylated, nonfunctionalized protein. The molecular 
ion peak was broadly dispersed over 66 430 Da due to an 
isotopic effect relative to the size of the protein (Figure 2A). 
The m/z ratio increases and peak position shifts to the right as 
BSA functionalized with PBA and the amount of shift is 
directly correlated to the amount of PBA conjugated to BSA 
(Figure 2A(2,3,4)). As a result, three BSA-PBA conjugates 
were obtained with the PBA/BSA ratio increase in the 
reactions, affording BSA-PBA1 determined to have 5 PBA 
functionalities, BSA-PBA2 to have 10 PBA, and BSA-PBA3 
to have 15 PBA functionalities. The MALDI-TOF MS spectra 
of BSA (1) and BSA mixed with PBA in different ratios but 
without EDC (Figure 2B(2-4)) showed no molecular weight 
change, indicating no PBA conjugation occurred. These data 
further confirmed that the BSA-PBA conjugates were 
successfully synthesized.
Figure 3. Alizarin Red S (ARS) displacement assay in PBS (pH 7.4). (A) ARS solutions after incubation with PBA or BSA -PBA conjugates and 
then fructose: (1) ARS, (2) ARS mixed with free PBA, (3) ARS mixed with free PBA, then with fructose, (4) ARS mixed with free BSA, (5) ARS 
mixed with BSA-PBA, (6) ARS mixed with BSA, then with fructose, (7) BSA. (B) UV spectra of ARS solutions after incubation with PBA or 
BSA-PBA conjugates then fructose: (1) ARS, (2) ARS mixed with free PBA, (3) ARS mixed with free PBA, then with fructose, (4) ARS mixed 
with free BSA, (5) ARS mixed with BSA-PBA, (6) ARS mixed with BSA-PBA, then with fructose, (7) BSA.
Carbohydrate-Binding Capacity of BSA-PBA Con­
jugates. The carbohydrate-binding capacity of BSA-PBA 
conjugates was examined by ARS displacement assay, which 
has been used extensively to quantify boronic acid and
carbohydrate-binding capabilities.25-27 Briefly, ARS shows a 
color change from red to yellow when bound to BSA-PBA 
and shifts the UV absorption wavelength from 520 to 460 nm 
in phosphate-buffered saline (PBS, pH 7.4). When adding a 
(0.1 M) fructose, the fructose-boronic acid complex forms, 
releasing ARS with the color changing from yellow back to red 
and the wavelength shifting back to 520 nm (Figure 3B).
Silica beads have been widely used as small, rigid particles 
for high-performance affinity chromatography and are capable 
of withstanding high flow rates and/or pressures. Recently, 
surface-functionalized silica beads have received widespread 
attention for affinity chromatography applications.28,29 In the 
present study, BSA-PBA conjugates were immobilized onto 
maleimide-functionalized silica beads, and their respective 
carbohydrate-binding affinity and specificity were investigated. 
First, BSA-PBA was dissolved in 0.1 mM PBS (pH 7.4). This 
BSA-PBA solution was added to commercially available 
maleimide-functionalized silica beads (Sigma) and the thiol- 
maleimide coupling reaction was allowed at room temperature 
for 4 h. Then, the unreacted BSA-PBA was removed by 
washing the silica beads with 0.1 mM PBS (pH 7.4) three 
times to afford BSA-PBA-functionalized silica beads (SB- 
BSA-PBA). Then, the resultant SB-BSA-PBA was charac­
terized by ARS binding assays compared to BSA-modified 
silica beads and untreated maleimide-functionalized silica 
beads as well. As a result, SB-BSA-PBA incubated with 
ARS solution showed strong ARS binding compared to 
unmodified silica beads and BSA-modified silica beads 
incubated with the same ARS solution.
Next, the SB-BSA-PBA was used to evaluate the 
carbohydrate-binding affinity and specificity by ARS displace­
ment assay. First, SB-BSA-PBA (15 mg) was incubated with 
ARS (0.1 μM) in PBS (pH 7.4) at room temperature for 30 
min. After centrifugation, the supernatant containing unreacted 
ARS was removed by a pipette and the silica beads were 
washed three times with PBS (pH 7.4). Among the BSA-PBA
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conjugates used, the BSA-PBA3-modified silica beads 
displayed the highest binding of ARS, as it has higher density 
of PBA compared to BSA-PBA1 and BSA-PBA2 (Figure 4). 
The BSA-modified silica beads and silica gel beads alone 
showed no ARS released and were subtracted as controls 
during the experiment. To support this evidence, ARS 
displacement by the introduction of a high concentration 
(0.1 M) of saccharides was investigated. This method has been 
used in the past to determine multiple facets of PBA binding to 
include saccharide kinetics, affinity, and specificity.30 The ARS- 
bound SB-BSA-PBA was incubated with free monosacchar­
ides solution (0.1 M) in PBS (pH 7.4) at room temperature for 
30 min to displace the bound ARS from the SB-BSA-PBA. In 
addition, their O-methyl glycosides of all sugars were 
investigated, and O-methyl glycosides mimic the native form 
of sugars in glycan chains linked via O-glycosylation. The 
displaced ARS was subjected to UV-vis spectroscopy, and the 
corresponding absorbance data were in direct correlation with 
the amount of ARS released from the SB-BSA-PBA, which is 
the indicator of the binding affinity and specificity of BSA- 
PBA conjugates to free monosaccharides and their O-methyl 
glycosides. As a result, BSA-PBA3 conjugates with the highest 
density of PBA showed the highest binding capacity for both 
free monosaccharides and their O-methyl glycosides compared 
to BSA-PBA1- and BSA-PBA2-modified silica beads (Figure 
4). However, there was no significant difference observed 
regarding specificity for both monosaccharides and their O- 
methyl glycosides. This result indicates that the SB-BSA-PBA 
binding is dependent on the number of PBAs on BSA, but it is 
unknown based on this assay if the saccharide truly makes a 
difference.
Figure 4. Carbohydrate-binding capacity of BSA-PBA measured by ARS replacement assay immobilized on silica gel beads. BSA-PBA conjugates 
were immobilized onto maleimide-functionalized silica gel, incubated with ARS, followed by washing and incubation with monosaccharides and 
their O-methyl glycoside. Absorbance at 520 nm was recorded for the free ARS replaced by sugars from the beads (sialic acid: Neu5Ac, sialoside: 2-
α-O-Methyl glycoside of Neu5Ac).
Figure 5. MTT assay. Raw 264.7 cells were incubated with BSA, PBA, and BSA-PBA conjugates for 24 h at 37 °C. The error bars represent one 
standard deviation of the averaged cell percent viability (n = 3).
Evaluation of Biocompatibility of BSA-PBA Con­
jugates. The relative cytotoxicity of BSA-PBA conjugates 
toward Raw 264.7 cells was estimated by an 3-(4,5-di- 
methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
viability assay. Briefly, Raw 264.7 cells were seeded into 96-well
plates at a density of 1 X 104 per well in 200 uL of medium.
After 24 h of incubation, the culture medium was removed and
replaced with 200 μL of media containing serial dilutions of 
BSA-PBA conjugates. The cells were grown for another 24 h. 
Then, 200 μL of 0.5 mg/mL MTT assay stock solution, in 
phenol red free medium, was added to each well. After 
incubating the cells for 4 h, the medium having unreacted dye 
was removed carefully. The obtained purple formazan crystals 
were dissolved in 100 μL SDS-HCl per well, and the 
absorbance was measured at 570 nm. As a result, no apparent 
cytotoxicity to Raw 264.7 cells was observed up to a high 
concentration of 1 uM for all three BSA-PBA conjugates. 
Instead, certain level of cell proliferation was observed for 
higher concentration of the three BSA-PBA conjugates 
(Figure 5).
Evaluation of Cell Surface Glycan-Binding Capability 
of BSA-PBA Conjugates. SAs are found linked to galactose 
residues by either a-2,3 or a-2,6 linkage on the cell surface.31 
In this study, the binding capacity of BSA-PBA conjugates to 
cell surface SA was determined via competitive inhibition of 
the binding of lectins that specifically recognize SA by flow 
cytometry analysis. First, Raw 264.7 cells were incubated with 
BSA-PBA conjugates for 90 min, followed by incubation with 
MAA-FITC and SNA-FITC, which specifically bind to a-2,3 
and a-2,6-linked SAs, respectively.32 From the flow cytometry 
study (Figure 6), MAA-FITC showed very strong binding
13470 DOI: 10.1021/acsomega.8b00840
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■ CONCLUSIONS
BSA-PBA conjugates were successfully synthesized, and their 
glycan recognition has been demonstrated as lectin mimetics. 
The conjugates were synthesized in a density-controlled 
manner using traditional EDC coupling, affording amide 
derivatives from carboxylic acid residues within the BSA. 
The BSA-PBA conjugates were characterized by SDS-PAGE 
and MALDI-TOF MS. The BSA-PBA conjugates were 
immobilized onto maleimide-functionalized silica gel via 
thiol-maleimide interactions and used to study the sugar­
binding capacity by ARS displacement assay. Evaluation of 
biocompatibility using an MTT assay showed no effect on cell
Figure 6. Cell surface SA binding capacity of BSA-PBA lectin 
mimetics. Raw 264.7 cells were incubated with BSA, BSA-PBA
conjugate (5 μg/mL), followed by MAA and SNA lectin (10 μg/mL).
The error bars indicate one standard deviation of the averaged
fluorescence intensity (n = 3).
compared to SNA-FITC on the cell surface of Raw 264.7 cells, 
cultured under the normal condition. And it was apparent that 
BSA-PBA could inhibit binding of MAA-FITC by blocking 
available binding sites with respect to the number of PBA 
residues available from BSA-PBA for interaction. SNA-FITC, 
on the other hand, showed a drastic decrease in binding when 
incubated with BSA-PBA1 cells, followed by an increase in 
fluorescence intensities with BSA-PBA2 and BSA-PBA3, 
which have high PBA content. This inverse relationship may be 
due to PBA location or geometry is different in these three 
BSA-PBA conjugates and their ability to bind cell surface SAs 
may be different, thereby having different inhibition capacities
for SNA binding. It is known that MAA and SNA specifically
bind to a-2,3- and a-2,6-linked SAs as they have different 
binding sites and different SA geometry preferences.32 It may 
also be possible that BSA-PBA2 and BSA-PBA3 may induce 
more expression of a-2,6-linked SAs, resulting in an increase in 
the fluorescence intensity of the SNA-FITC. This phenomen­
on is correlated to the MTT assay data (Figure 5), in which 
BSA-PBA2 and BSA-PBA3 conjugates were able to 
proliferate the concentration of cells. To confirm all of these 
speculations, we plan to design more BSA-PBA conjugates 
and characterize their PBA conjugation location and quantify 
cell surface SA expression of macrophage upon incubation with 
these lectin mimetics in detail in our future study. To explain 
the reduction in fluorescence intensity caused by the BSA 
control, it is possible that the BSA may limit this effect, 
showing true 100% lectin binding.
viability after 24 h. Finally, cellular studies confirmed the 
binding of BSA-PBA conjugates to the cell surface SA of Raw 
264.7 cells based on the inhibition of lectin-FITC binding. 
These lectin mimetics have more favorable properties 
compared to natural lectin in terms of toxicity and inherent 
immunogenicity and will provide a valuable tool for future 
glycomics, biosensor, and immunomodulation research and 
applications.■ EXPERIMENTAL SECTION
Materials and Instruments. All solvents and reagents 
were purchased from commercial sources and were used as 
received, unless otherwise noted. Deionized water was used as 
a solvent in all procedures. 3-Aminophenylboronic acid, 
Alizarin Red S (ARS), BSA, N-(3-(dimethylamino)propyl)- 
N-ethylcarbodiimide, 3-(4,5-di-methylthiazol-2-yl)-2,5-diphe- 
nyltetrazolium bromide (MTT), and maleimide-functionalized 
silica beads and Sephadex G-25 were purchased from Sigma- 
Aldrich (St. Louis, MO). Glucose, methyl β-O-glucopyrano- 
side, galactose, methyl β-O-galactopyranoside, mannose, 
methyl α-O-mannopyranoside, sialic acid, and lactose were 
purchased from Sigma-Aldrich (St. Louis, MO). MAA-FITC 
and SNA-FITC were purchased from Bio-World (Dublin, 
OH). 2-a-O-Methyl glycoside of Neu5Ac was synthesized by a 
literature method.33
Synthesis of BSA-PBA Conjugates. BSA (100 mg, 30
μM) and 3-aminophenylboronic acid (30 mg, 400 mM) were 
dissolved in 5 mL of 0.05 M 2-(N-morpholino)ethane sulfonic 
acid buffer (MES; pH 6.0). To this mixture, N-(3- 
(dimethylamino)propyl)-N-ethylcarbodiimide hydrochloride 
(EDC; 15 mg, 80 μM) was added under constant stirring 
and allowed to react overnight at room temperature. Then, the 
reaction mixture was subjected to a Sephadex G-25 column 
with diH2O as eluent for purification and lyophilized. BSA- 
PBAs of different densities were prepared using the same 
procedure as above by changing the ratios of BSA to PBA. 
Characterization was carried out by SDS-PAGE using both 
Coomassie blue and ARS as stains and imaged on a Typhoon 
9410 Variable Mode Imager.
Matrix-Assisted Laser Desorption Ionization/Time-of- 
Flight Mass Spectrometry (MALDI-TOF MS). The high 
purities and expected structures of the conjugated BSA-PBA 
derivatives were verified by MALDI-TOF MS using a Bruker 
Autoflex III MALDI-TOF mass spectrometer. The sample was 
applied onto the target plate using the dry droplet technique, 
in which 1 μL of sample containing 1 μg of total protein in 
0.1% trifluoroacetic acid (TFA) was mixed with 1 μL of matrix 
(20 mg/mL sinappic acid in 0.1% TFA, 40% acetonitrile). The 
spots were dried at room temperature to allow sample 
crystallization prior to insertion into the instrument, and the 
spectrum was obtained in linear mode.
Immobilization of BSA-PBA onto Silica Beads. BSA- 
PBA (45 mg, 2 mM) and maleimide-functionalized silica beads 
(250 mg) were incubated in PBS (3 mL, 0.1 M, pH 7.4) for 4 
h at room temperature. The reaction mixture was then 
centrifuged and washed with 0.1 M PBS (pH 7.4) three times 
to remove unreacted BSA-PBA. The same procedure was 
used for immobilization of all BSA-PBA conjugates as well as 
unmodified BSA.
Alizarin Red S Binding and Displacement Assay of 
BSA-PBA on Silica Beads. BSA-PBA-modified silica beads 
(15 mg) were incubated with ARS (400 ¿M) in PBS (1 mL, 
0.1 M, pH 7.4) for 30 min at room temperature and
13471 DOI: 10.1021/acsomega.8b00840
ACS Omega 2018, 3, 13467-13473
ACS Omega Article
centrifuged to remove unreacted ARS. The beads were then 
centrifuged and washed with 0.1 M PBS (pH 7.4) three times 
to remove unreacted or loosely bound ARS, followed by
incubation of these silica beads with 100 mM sugar solutions
(glucose, methyl β-O-glucopyranoside, galactose, methyl β-O- 
galactopyranoside, mannose, methyl α-O-mannopyranoside, 
Neu5Ac, 2-a-O-methyl glycoside of Neu5Ac, and lactose) in 
0.1 M PBS (1 mL, pH 7.4) for 30 min at room temperature. 
Supernatant containing displaced ARS was removed after 
centrifugation and subjected to UV-vis spectroscopy. The 
absorbance of each well was measured on a microplate reader 
(Molecular Devices Spectrometer Plus 384) at 520 nm.
Cell Culture Methods. Raw 264.7 cells (ATCC) were 
cultured using Dulbecco's modified Eagle's medium supple­
mented with 10% fetal bovine serum and 1% penicillin/ 
streptavidin at 37 °C in a humidified 5% CO2 atmosphere. 
Subculture was performed when the cells had 80-90% 
confluence using trypsin-ethylenediaminetetraacetic acid.
MTT Assay. The biocompatibility of the BSA-PBA 
conjugates was measured by 3-(4, 5-di-methylthiazol-2-yl)-2, 
5-diphenyltetrazolium bromide (MTT) assay. Raw 264.7 cells 
(ATCC) were seeded in 96-well plates at a density of 1 X 104 
cells/well in medium and incubated for 24 h at 37 °C (5% 
CO2). After 24 h, the medium was replaced with a new 
medium, supplemented with BSA-PBA conjugates, at varying 
concentrations (0.062, 0.125, 0.25, 0.5, and 1 μM). After an 
additional 24 h, the cell medium was again removed and 100 
μL of 5 mg/mL MTT solution was added to each well, and the 
plates were incubated for 4 h. The MTT solution was removed 
and 100 iL of 1SDS-HCl per well was added to solubilize the 
precipitate, and the plates were shaken for 10 min. The 
absorbance of each well was measured on a microplate reader 
at 520 nm.
Competitive Inhibition of Lectin Binding to Macro­
phage Cell Surface SA by Flow Cytometry Analysis. Raw
264.7 cells were seeded at 4 X 105 cells/well (5 mL tubes) and 
treated with BSA-PBA conjugates for 90 min. The cells were 
then washed three times with cold phosphate-buffered saline 
(PBS; 0.2 mL, pH 7.4) and suspended in 50 iL of PBS (pH 
7.4) containing MAA-FITC (10 ig/mL) or SNA-FITC (10 
ig/mL). After incubation for 30 min at room temperature, the 
cells were washed with cold PBS (pH 7.4) three times and 
resuspended in 500 iL of the same buffer for flow analysis. A 
minimum of 10 000 cells were measured each time. The 
fluorescence intensity of fluorescein-labeled lectins was 
subtracted from the intensity of the cell-lectin complex. All 
experiments were carried out in triplicate and spectra were 
obtained on a BD FACSCanto II Flow Cytometer.
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